FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154927053> ?p ?o ?g. }

• W3154927053 abstract "Abstract Background Progress toward the global target for 95% virological suppression among those on antiretroviral treatment (ART) is still suboptimal. We describe the viral load (VL) cascade, the incidence of virological failure and associated risk factors among people living with HIV receiving first-line ART in an HIV cohort in Myanmar treated by the Médecins Sans Frontières in collaboration with the Ministry of Health and Sports Myanmar. Methods We conducted a retrospective cohort study, including adult patients with at least one HIV viral load test result and having received of at least 6 months’ standard first-line ART. The incidence rate of virological failure (HIV viral load ≥ 1000 copies/mL) was calculated. Multivariable Cox’s regression was performed to identify risk factors for virological failure. Results We included 25,260 patients with a median age of 33.1 years (interquartile range, IQR 28.0–39.1) and a median observation time of 5.4 years (IQR 3.7–7.9). Virological failure was documented in 3,579 (14.2%) participants, resulting in an overall incidence rate for failure of 2.5 per 100 person-years of follow-up. Among those who had a follow-up viral load result, 1,258 (57.1%) had confirmed virological failure, of which 836 (66.5%) were switched to second-line treatment. An increased hazard for failure was associated with age ≤ 19 years (adjusted hazard ratio, aHR 1.51; 95% confidence intervals, CI 1.20–1.89; p < 0.001), baseline tuberculosis (aHR 1.39; 95% CI 1.14–1.49; p < 0.001), a history of low-level viremia (aHR 1.60; 95% CI 1.42–1.81; p < 0.001), or a history of loss-to-follow-up (aHR 1.24; 95% CI 1.41–1.52; p = 0.041) and being on the same regimen (aHR 1.37; 95% CI 1.07–1.76; p < 0.001). Cumulative appointment delay was not significantly associated with failure after controlling for covariates. Conclusions VL monitoring is an important tool to improve programme outcomes, however limited coverage of VL testing and acting on test results hampers its full potential. In our cohort children and adolescents, PLHIV with history of loss-to-follow-up or those with low-viremia are at the highest risk of virological failure and might require more frequent virological monitoring than is currently recommended." @default.
• W3154927053 created "2021-04-26" @default.
• W3154927053 creator A5003499945 @default.
• W3154927053 creator A5007828254 @default.
• W3154927053 creator A5010344676 @default.
• W3154927053 creator A5014839628 @default.
• W3154927053 creator A5015297485 @default.
• W3154927053 creator A5021161270 @default.
• W3154927053 creator A5023905185 @default.
• W3154927053 creator A5027612390 @default.
• W3154927053 creator A5028128458 @default.
• W3154927053 creator A5031626110 @default.
• W3154927053 creator A5033523318 @default.
• W3154927053 creator A5041857145 @default.
• W3154927053 creator A5045863751 @default.
• W3154927053 creator A5054601206 @default.
• W3154927053 creator A5059489482 @default.
• W3154927053 creator A5069146709 @default.
• W3154927053 creator A5070146815 @default.
• W3154927053 creator A5072771144 @default.
• W3154927053 date "2021-04-21" @default.
• W3154927053 modified "2023-10-14" @default.
• W3154927053 title "Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis" @default.
• W3154927053 cites W1494300042 @default.
• W3154927053 cites W1952524289 @default.
• W3154927053 cites W1989878476 @default.
• W3154927053 cites W2072076097 @default.
• W3154927053 cites W2102525796 @default.
• W3154927053 cites W2103117652 @default.
• W3154927053 cites W2114277941 @default.
• W3154927053 cites W2152271733 @default.
• W3154927053 cites W2162619707 @default.
• W3154927053 cites W2215476268 @default.
• W3154927053 cites W2238127173 @default.
• W3154927053 cites W2239032355 @default.
• W3154927053 cites W2326117550 @default.
• W3154927053 cites W2471370734 @default.
• W3154927053 cites W2514145503 @default.
• W3154927053 cites W2565977513 @default.
• W3154927053 cites W2568924655 @default.
• W3154927053 cites W2586334251 @default.
• W3154927053 cites W2747680863 @default.
• W3154927053 cites W2755255935 @default.
• W3154927053 cites W2767927145 @default.
• W3154927053 cites W2769267084 @default.
• W3154927053 cites W2788088802 @default.
• W3154927053 cites W2790367178 @default.
• W3154927053 cites W2793836027 @default.
• W3154927053 cites W2834221712 @default.
• W3154927053 cites W2888515292 @default.
• W3154927053 cites W2890937674 @default.
• W3154927053 cites W2897502278 @default.
• W3154927053 cites W2911770891 @default.
• W3154927053 cites W2912092373 @default.
• W3154927053 cites W2936279454 @default.
• W3154927053 cites W2936668056 @default.
• W3154927053 cites W2936745271 @default.
• W3154927053 cites W2951663793 @default.
• W3154927053 cites W2961470236 @default.
• W3154927053 cites W2970557673 @default.
• W3154927053 cites W2982378076 @default.
• W3154927053 cites W2990676722 @default.
• W3154927053 cites W2994005656 @default.
• W3154927053 cites W3004902703 @default.
• W3154927053 cites W3011059215 @default.
• W3154927053 cites W3015356306 @default.
• W3154927053 doi "https://doi.org/10.1186/s12981-021-00336-0" @default.
• W3154927053 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8059266" @default.
• W3154927053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33882962" @default.
• W3154927053 hasPublicationYear "2021" @default.
• W3154927053 type Work @default.
• W3154927053 sameAs 3154927053 @default.
• W3154927053 citedByCount "12" @default.
• W3154927053 countsByYear W31549270532022 @default.
• W3154927053 countsByYear W31549270532023 @default.
• W3154927053 crossrefType "journal-article" @default.
• W3154927053 hasAuthorship W3154927053A5003499945 @default.
• W3154927053 hasAuthorship W3154927053A5007828254 @default.
• W3154927053 hasAuthorship W3154927053A5010344676 @default.
• W3154927053 hasAuthorship W3154927053A5014839628 @default.
• W3154927053 hasAuthorship W3154927053A5015297485 @default.
• W3154927053 hasAuthorship W3154927053A5021161270 @default.
• W3154927053 hasAuthorship W3154927053A5023905185 @default.
• W3154927053 hasAuthorship W3154927053A5027612390 @default.
• W3154927053 hasAuthorship W3154927053A5028128458 @default.
• W3154927053 hasAuthorship W3154927053A5031626110 @default.
• W3154927053 hasAuthorship W3154927053A5033523318 @default.
• W3154927053 hasAuthorship W3154927053A5041857145 @default.
• W3154927053 hasAuthorship W3154927053A5045863751 @default.
• W3154927053 hasAuthorship W3154927053A5054601206 @default.
• W3154927053 hasAuthorship W3154927053A5059489482 @default.
• W3154927053 hasAuthorship W3154927053A5069146709 @default.
• W3154927053 hasAuthorship W3154927053A5070146815 @default.
• W3154927053 hasAuthorship W3154927053A5072771144 @default.
• W3154927053 hasBestOaLocation W31549270531 @default.
• W3154927053 hasConcept C119060515 @default.
• W3154927053 hasConcept C120665830 @default.
• W3154927053 hasConcept C121332964 @default.
• W3154927053 hasConcept C126322002 @default.
• W3154927053 hasConcept C142462285 @default.

• next